SL Science Holding Limited (NasdaqGM: SLBT)
Health Care · Biotechnology · TW
$0.73
-4.88% today · -93.0% 1Y
SL Science Holding Limited (NasdaqGM: SLBT) operates in the Biotechnology industry within the Health Care sector. The company is valued at $414.58M and employs 15 people.
Over the last twelve months the share price has lost 93.0%, trading between 0.72 and 14.50.
Tweenvest scores SL Science Holding Limited across four factors: quality 65/100, value 48/100. Its strongest factor is quality.
SLBT price history
Key figures
- Market cap
- $414.58M
- Revenue (TTM)
- $3.27M
- P/E
- 1,038.97
- EPS
- -0.45
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- $14.50
- 52-week low
- $0.72
- Avg volume (3M)
- —
- Shares outstanding
- 570.27M
- Employees
- 15
- Next earnings
- —
About SL Science Holding Limited
SL Science Holding Limited manufactures cosmetic skin care and scalp care products. The company’s products include SL bio’s milk-derived exosome essence, SL bio’s tangerine-derived extract, and the MilkExo concentrate series. It also offers research services in armed T-cells, gamma delta T- cells, citrus reticulata (tangerine) extract, and milk-derived exosomes. SL Science Holding Limited was formerly known as SL BIO Co., Ltd. and changed its name to SL Science Holding Limited in June 2026. The company is based in Taipei, Taiwan.
- ISIN
- KYG8191L1169
- Listed since
- Feb 5, 2025
- Exchange
- Nasdaq Global Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| CytomX Therapeutics, Inc.NasdaqGS: CTMX | $422.93M | $1.94 | -2.27% |
| Rezolute, Inc.NasdaqCM: RZLT | $421.19M | $4.02 | +12.15% |
| Lifecome Biochemistry Co.,Ltd.SZSE: 002868 | $418.86M | CN¥17.99 | -1.75% |
| Qyuns Therapeutics Co., Ltd.SEHK: 2509 | $418.53M | HK$14.70 | -1.28% |
| Tectonic Therapeutic, Inc.NasdaqGM: TECX | $413.27M | $21.14 | +0.48% |
| Heartseed Inc.TSE: 219A | $413.11M | ¥2,885.00 | -0.69% |
| Onconic Therapeutics Inc.KOSDAQ: A476060 | $407.62M | ₩12,000.00 | -4.53% |
| Hubei Goto Biopharm Group Co., Ltd.SZSE: 300966 | $407.22M | CN¥23.80 | -4.57% |